CareView Communications Inc 8-K

What Happened

• CareView Communications, Inc. (CRVW) reported in an 8-K that, as of December 31, 2025, it and its wholly owned subsidiary borrower entered into a Thirteenth Amendment to the Credit Agreement with PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.). The amendment extends the Credit Agreement’s Maturity Date to March 31, 2026. The amendment lists Steven G. Johnson (President & CEO) and director Dr. James R. Higgins as parties to the amendment. A copy of the amendment is filed as Exhibit 10.45.

Key Details

• Amendment effective date: December 31, 2025 (as reported).
• New Maturity Date: March 31, 2026.
• Lender/administrative agent: PDL Investment Holdings, LLC (assignee of PDL BioPharma, Inc.).
• Document filed as Exhibit 10.45 to the Form 8‑K.

Why It Matters

• The amendment postpones the loan repayment deadline, giving CareView more time before the debt becomes due (now March 31, 2026). That affects the company’s near-term financing and liquidity timeline.
• Investors should note this is a material amendment to an existing credit facility and reflects the company’s ongoing financing arrangements with PDL; the full amendment text is available in the exhibit for details on any other covenant or payment changes.